Naprosyn
- Product NDC
- 69437-316
- 11-digit product format
- 694370316
- Labeler code
- 69437
- Product ID
- 69437-316_30e34aeb-4e90-4ba5-adc7-343806b104c6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- naproxen
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Canton Laboratories
- Application
- NDA017581
- Marketing category
- NDA
- Marketing start
- 2016-06-01
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69437-316 | NAPROSYN (NAPROXEN) TABLET EC-NAPROSYN (NAPROXEN) TABLET, DELAYED RELEASE ANAPROX DS (NAPROXEN SODIUM) TABLET [CANTON LABORATORIES] | 12 | Legacy NDC | 20250105_8bff5df5-d856-4237-b6a8-ae445b454844.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69437-316-01 | 69437031601 | 100 TABLET in 1 BOTTLE, PLASTIC (69437-316-01) | 100 tablet | 2016-06-01 | 0000-00-00 | No | No | Current |